These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31776770)

  • 41. Tryptase: The Silent Witness of Past and Ongoing Systemic Events.
    Oštrić Pavlović I; Radović S; Krtinić D; Spirić J; Kusić N; Veličković A; Tomić-Spirić V
    Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336421
    [No Abstract]   [Full Text] [Related]  

  • 42. Hereditary Alpha Tryptasemia: Validation of a Single-Well Multiplex Digital Droplet PCR Assay in a Cohort of Symptomatic Patients.
    Alheraky A; Wierenga ATJ; Simpelaar A; Hesp LB; Minovic I; Bagheri N; Roozendaal C; Span LFR; Oude Elberink HNG; Kema IP; Mulder AB
    Clin Chem; 2024 Feb; 70(2):425-433. PubMed ID: 38073287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mast Cell Activation During Suspected Perioperative Hypersensitivity: A Need for Paired Samples Analysis.
    Ebo DG; De Puysseleyr LP; Van Gasse AL; Elst J; Poorten MV; Faber MA; Mertens C; Van Houdt M; Hagendorens MM; Sermeus L; Vitte J; Moise M; Garvey LH; Castells MC; Tacquard C; Mertes PM; Schwartz LB; Sabato V
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3051-3059.e1. PubMed ID: 33862269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basal serum tryptase: A critical reconsideration of reference values.
    Francois F; Mauff BL; Waeckel L; de Chaisemartin L; Tabary T; Dumontet E; Lecron JC; Delamare B; Boumediene A; Chauvineau-Grenier A; Pescarmona R; Garnier L; Lambert C;
    Allergy; 2023 Nov; 78(11):3003-3006. PubMed ID: 37357803
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.
    Giannetti MP; Godwin G; Weller E; Butterfield JH; Castells M
    J Allergy Clin Immunol; 2022 Nov; 150(5):1225-1227. PubMed ID: 35550148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
    Butterfield JH
    Int Arch Allergy Immunol; 2020; 181(1):43-50. PubMed ID: 31722348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis.
    Vitte J; Sabato V; Tacquard C; Garvey LH; Michel M; Mertes PM; Ebo DG; Schwartz LB; Castells MC
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2994-3005. PubMed ID: 33746087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The serum tryptase test: an emerging robust biomarker in clinical hematology.
    Valent P; Sperr WR; Sotlar K; Reiter A; Akin C; Gotlib J; Horny HP; Arock M
    Expert Rev Hematol; 2014 Oct; 7(5):683-90. PubMed ID: 25169217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
    Valent P; Hoermann G; Bonadonna P; Hartmann K; Sperr WR; Broesby-Olsen S; Brockow K; Niedoszytko M; Hermine O; Chantran Y; Butterfield JH; Greiner G; Carter MC; Sabato V; Radia DH; Siebenhaar F; Triggiani M; Gülen T; Alvarez-Twose I; Staudinger T; Traby L; Sotlar K; Reiter A; Horny HP; Orfao A; Galli SJ; Schwartz LB; Lyons JJ; Gotlib J; Metcalfe DD; Arock M; Akin C
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3010-3020. PubMed ID: 37572755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
    J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
    Thomas EG; Thomas DJ
    Emerg Med Clin North Am; 2022 Feb; 40(1):119-133. PubMed ID: 34782083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.
    van Anrooij B; van der Veer E; de Monchy JG; van der Heide S; Kluin-Nelemans JC; van Voorst Vader PC; van Doormaal JJ; Oude Elberink JN
    J Allergy Clin Immunol; 2013 Jul; 132(1):125-30. PubMed ID: 23498593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The presence of mast cell clonality in patients with unexplained anaphylaxis.
    Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary Alpha-Tryptasemia: UK Prevalence and Variability in Disease Expression.
    Robey RC; Wilcock A; Bonin H; Beaman G; Myers B; Grattan C; Briggs TA; Arkwright PD
    J Allergy Clin Immunol Pract; 2020; 8(10):3549-3556. PubMed ID: 32553831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A; Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to interpret mast cell tests.
    Waterfield T; Dyer E; Wilson K; Boyle RJ
    Arch Dis Child Educ Pract Ed; 2016 Oct; 101(5):246-51. PubMed ID: 27325614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tryptase in drug-induced anaphylaxis: the need for acute and baseline values.
    Michel M; Giusti D; Klingebiel C; Vitte J
    Curr Opin Allergy Clin Immunol; 2024 Oct; 24(5):293-299. PubMed ID: 39079161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.